CDDO-EA-CDDO-ethyl-amide-DataSheet-生命科學試劑-MedChemExpress_第1頁
CDDO-EA-CDDO-ethyl-amide-DataSheet-生命科學試劑-MedChemExpress_第2頁
CDDO-EA-CDDO-ethyl-amide-DataSheet-生命科學試劑-MedChemExpress_第3頁
CDDO-EA-CDDO-ethyl-amide-DataSheet-生命科學試劑-MedChemExpress_第4頁
全文預覽已結束

下載本文檔

版權說明:本文檔由用戶提供并上傳,收益歸屬內容提供方,若內容存在侵權,請進行舉報或認領

文檔簡介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemECDDO-EACat. No.: HY-12213CAS No.: 932730-51-3Synonyms: CDDO ethyl amide; TP319; RTA 405分式: CHNO分量: 518.73作靶點: Keap1-Nrf2作通路: NF-B儲存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性數(shù)據(jù)體外實驗 DMSO : 34 mg/mL (65

2、.54 mM)* means soluble, but saturation unknown.Mass Solvent1 mg 5 mg 10 mg Concentration制備儲備液1 mM 1.9278 mL 9.6389 mL 19.2779 mL5 mM 0.3856 mL 1.9278 mL 3.8556 mL10 mM 0.1928 mL 0.9639 mL 1.9278 mL請根據(jù)產(chǎn)品在不同溶劑中的溶解度,選擇合適的溶劑配制儲備液,并請注意儲備液的保存式和期限。體內實驗請根據(jù)您的實驗動物和給藥式選擇適當?shù)娜芙獍?,配制前請先配制澄清的儲備液,再依次添加助溶?為保證實驗結果的可靠

3、性,體內實驗的作液,建議您現(xiàn)現(xiàn)配,當天使;澄清的儲備液可以根據(jù)儲存條件,適當保存;以下溶劑前的百分 指該溶劑在您配制終溶液中的體積占):1. 請依序添加每種溶劑: 10% DMSO 40% PEG300 5% Tween-80 45% salineSolubility: 2.5 mg/mL (4.82 mM); Suspended solution; Need ultrasonic2. 請依序添加每種溶劑: 10% DMSO 90% (20% SBE-CD in saline)Solubility: 2.5 mg/mL (4.82 mM); Clear solution1/3 Master o

4、f Small Molecules 您邊的抑制劑師www.MedChemE3. 請依序添加每種溶劑: 10% DMSO 90% corn oilSolubility: 2.5 mg/mL (4.82 mM); Clear solutionBIOLOGICAL ACTIVITY物活性 CDDO-EA種 NF-E2 相關因 2 /抗氧化反應元件 (Nrf2/ARE) 激活劑。IC50 & Target Nrf2/ARE 1體外研究 CDDO-EA potently activates Nrf2/ARE in a cell culture model of ALS and in the G93A S

5、OD1 mouse model ofALS 1. CDDO-EA is a potent inducer of apoptosis in A549 lung cancer cells, as shown both by PARPcleavage and Annexin staining. CDDO-EA is more potent than CDDO itself as inducers of heme oxygenase-1 (HO-1). In RAW264.7 macrophage-like cells, CDDO-EA is 7-fold more potent than CDDO

6、as suppressorsof the ability of IFN- to induce iNOS 2.體內研究 The survival analysis shows that G93A mice treated with CDDO-EA, compared to G93A littermate controls,lives significantly longer. CDDO-EA treatment increases the life-span by 20.6 days from 124.053.7 days to144.728.1 days (16.6%) (p 1.PROTOC

7、OLCell Assay 1 Wild-type and Nrf2/ mouse embryonic fibroblasts are pre-treated with CDDO-EA or CDDO-TFEA atvarious concentrations (1, 10 and 100 nM in DMSO) for 18 hours and incubated with 2,7-Dichlorodihydrofluorecein diacetate (H2DCFDA) for 30 min. Cells are challenged with 250 M tBHP for 15-30min

8、 and the mean fluorescence intensity for 10,000 cells is analyzed by FACSan flow cytometry using a480-nm excitation wavelength and a 525-nm emission wavelength 1.MCE has not independently confirmed the accuracy of these methods. They are for reference only.Animal Mice 1Administration 1 G93A SOD1 tra

9、nsgenic familial ALS mice (high copy number) B6SJL background strain (G93A SOD1,B6SJL-TgGur1) are used. G93A transgenic mice are assigned randomly to the control (vehicle, mouse chawonly) and to mouse chaw containing either CDDO-EA or CDDO-TFEA (400 mg/kg of food, n=30 in bothgroups). This dose corr

10、esponds to about 80 mg/kg body weight/day, assuming each mouse consumes 5grams of food per day. We found mice can tolerate this dose. Treatments started at two different timeregimens: 1) “Early” at 30 days of age, about two months prior to symptom onset; 2) “At Onset” from theonset of the phenotype

11、(80-90 days of age). A diet consisting of either 400 mg of CDDO-TFEA per kg of foodor 400 mg of CDDO-EA per kg of food, and a control lab diet, are prepared by Purina.MCE has not independently confirmed the accuracy of these methods. They are for reference only.戶使本產(chǎn)品發(fā)表的科研獻 J Cell Mol Med. 2019 Jun 2

12、1.2/3 Master of Small Molecules 您邊的抑制劑師www.MedChemESee more customer validations on HYPERLINK / www.MedChemEREFERENCES1. Neymotin A, et al. Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model ofamyotrophic lateral sclerosis. Free Radic Biol Med. 2011 Jul 1;51(1):88-96.2. Liby K, et al. The synthetic triterpenoids CDDO-methyl ester and CDDO-ethyl amide prevent lung cancer induced by vinyl carbamate inA/J mice. Cancer Res. 2007 Mar 15;67(6):2414-9.McePdfHeigh

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內容里面會有圖紙預覽,若沒有圖紙預覽就沒有圖紙。
  • 4. 未經(jīng)權益所有人同意不得將文件中的內容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內容本身不做任何修改或編輯,并不能對任何下載內容負責。
  • 6. 下載文件中如有侵權或不適當內容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

評論

0/150

提交評論